Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells

Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3... J Mol Med (2017) 95:965–975 DOI 10.1007/s00109-017-1549-x ORIGINAL ARTICLE Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells 1,2,3,4 5,6 5 7,8 Chun-Yu Liu & Kuen-Feng Chen & Tzu-I Chao & Pei-Yi Chu & 2,9 1,4 1 10 Chun-Teng Huang & Tzu-Ting Huang & Hsiu-Ping Yang & Wan-Lun Wang & 1 1 1 11 1,2,3 Chia-Han Lee & Ka-Yi Lau & Wen-Chun Tsai & Jung-Chen Su & Chia-Yun Wu & 1,2,3 11 2,4,10 Ming-Huang Chen & Chung-Wai Shiau & Ling-Ming Tseng Received: 9 November 2016 /Revised: 7 May 2017 /Accepted: 19 May 2017 /Published online: 4 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract 43 in vitro showed enhanced anti-proliferation and apoptosis Triple negative breast cancer (TNBC) is an aggressive cancer associated with decreased p-STAT3 and decreased STAT3- for which prognosis remains poor. Combination therapy is a downstream effector cyclin D1 in the TNBC cell lines promising strategy for enhancing treatment efficacy. Blockade MDA-MB-231, MDA-MB-468, and HCC-1937. Ectopic ex- of STAT3 signaling may enhance the response of cancer cells pression of STAT3 reduced the increased cytotoxicity induced to conventional chemotherapeutic agents. Here we used a by the combination http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Molecular Medicine Springer Journals

Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells

Loading next page...
 
/lp/springer_journal/sequential-combination-of-docetaxel-with-a-shp-1-agonist-enhanced-sP9YH3pOjo
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Molecular Medicine; Human Genetics; Internal Medicine
ISSN
0946-2716
eISSN
1432-1440
D.O.I.
10.1007/s00109-017-1549-x
Publisher site
See Article on Publisher Site

Abstract

J Mol Med (2017) 95:965–975 DOI 10.1007/s00109-017-1549-x ORIGINAL ARTICLE Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells 1,2,3,4 5,6 5 7,8 Chun-Yu Liu & Kuen-Feng Chen & Tzu-I Chao & Pei-Yi Chu & 2,9 1,4 1 10 Chun-Teng Huang & Tzu-Ting Huang & Hsiu-Ping Yang & Wan-Lun Wang & 1 1 1 11 1,2,3 Chia-Han Lee & Ka-Yi Lau & Wen-Chun Tsai & Jung-Chen Su & Chia-Yun Wu & 1,2,3 11 2,4,10 Ming-Huang Chen & Chung-Wai Shiau & Ling-Ming Tseng Received: 9 November 2016 /Revised: 7 May 2017 /Accepted: 19 May 2017 /Published online: 4 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract 43 in vitro showed enhanced anti-proliferation and apoptosis Triple negative breast cancer (TNBC) is an aggressive cancer associated with decreased p-STAT3 and decreased STAT3- for which prognosis remains poor. Combination therapy is a downstream effector cyclin D1 in the TNBC cell lines promising strategy for enhancing treatment efficacy. Blockade MDA-MB-231, MDA-MB-468, and HCC-1937. Ectopic ex- of STAT3 signaling may enhance the response of cancer cells pression of STAT3 reduced the increased cytotoxicity induced to conventional chemotherapeutic agents. Here we used a by the combination

Journal

Journal of Molecular MedicineSpringer Journals

Published: Jun 4, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off